Clinical Trial Update: Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®) [Phase 3]

View source ↗

Summary

A Phase 3 study comparing ponesimod to placebo in active relapsing multiple sclerosis patients already treated with dimethyl fumarate was terminated; results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Ponesimod (ponesimod)

Snippet

Sponsor: Actelion | Conditions: Multiple Sclerosis | Phase 3 | Status: TERMINATED | Results posted: 2021-05-18